Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $609,364.00 |
|---|---|
| Enterprise Value | $1.66 Million |
| Earnings per Share | $0 |
| Beta | 0.26 |
| Outstanding Shares | 1,523,409,834 |
| P/E Ratio | -51.16 |
|---|---|
| PEG | -740.62 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 48714.88 |
| Enterprise Value to EBIT | -139.06 |
| Enterprise Value to Net Income | -140 |
| Total Debt to Enterprise | 0.63 |
| Debt to Equity | -0.91 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to ...